Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial

IntroductionCOVID-19 induces venous, arterial and microvascular thrombosis, involving several pathophysiological processes. In patients with severe COVID-19 without macrovascular thrombosis, escalating into high-dose prophylactic anticoagulation (HD-PA) or therapeutic anticoagulation (TA) could be b...

Full description

Saved in:
Bibliographic Details
Published in:BMJ open Vol. 12; no. 4; p. e059383
Main Authors: Labbe, Vincent, Contou, Damien, Heming, Nicholas, Megarbane, Bruno, Ait-Oufella, Hafid, Boissier, Florence, Carreira, Serge, Robert, Alexandre, Vivier, Emmanuel, Fejjal, Mohamed, Doyen, Denis, Monchi, Mehran, Preau, Sebastien, Noel-Savina, Elise, Souweine, Bertrand, Zucman, Noémie, Picos, Santiago Alberto, Dres, Martin, Juguet, William, Mariotte, Eric, Timsit, Jean-François, Turpin, Matthieu, Razazi, Keyvan, Gendreau, Ségolène, Baloul, Samia, Voiriot, Guillaume, Fartoukh, Muriel, Audureau, Etienne, Mekontso Dessap, Armand
Format: Journal Article
Language:English
Published: England British Medical Journal Publishing Group 26.04.2022
BMJ Publishing Group LTD
BMJ Publishing Group
Series:Protocol
Subjects:
ISSN:2044-6055, 2044-6055
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first